Committed to providing scientific clarity to MS care, we are proud to launch our new blog: Octave Note

Imaging

Making the invisible, visible

Quantitative and accurate MS-specific MRI reports

created by combining advanced technologies and image standardization with human expertise.

We can do better.

Introducing Octave’s MRI insights program, a new imaging technology that integrates the full spectrum of actionable information for quicker and more confident care decisions.

Lesion count and volume over time
arrow
Size, shape, orientation, distribution, location
arrow
McDonald Criteria defined metrics
arrow
Black Hole count
arrow
Brain Graphic
arrow
Measures of atrophy
arrow
Supporting citations
arrow
Key images highlighted
arrow
MS neuroradiologist expertise
arrow
Rigorous quality control

Key Applications

The Octave MS brain MRI helps you
Clarify diagnosis

Establish baseline before DMT switch

Measure therapy response

Detect change in disease activity

Improve routine surveillance

Monitor safety or serious adverse events

Case Study

Before-and-after neuroradiology reporting at an MS center of excellence

Before – Without Octave Imaging

This MS center of excellence already had its own MRI scanners and access to some quantitative metrics.

Before

After – With Octave Imaging

Subtle changes that can be missed by the human eye are clearly visible using our advanced images, metrics, and MS-specific view.

After

Without advanced imaging technology, this patient may have had to wait for their next MRI (or a clinical relapse) for their disease progression to register.

Subtle changes that can be missed by the human eye are clearly visible using our advanced images, metrics, and MS-specific view.

Download Full Case Study

See the Science

Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Download PDF  

Development of a Custom Multivariate Proteomic Serum Based Assay for Association with Radiographic and Clinical Endpoints in MS

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Download PDF  
View All Publications  

Get In Touch

Please reach out and we’ll be in touch soon.







 

*Required field

By submitting your information, you agree to receive emails from Octave and understand that you may opt out of Octave subscriptions at any time.